|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61P 5/26 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Patento numeris | 2824102 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14188300.9 |
| Europos patento paraiškos padavimo data | 2011-02-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-02-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 305082 P | 2010-02-16 | US | |
| 329023 P | 2010-04-28 | US | |
| 388457 P | 2010-09-30 | US |
| (72) |
Smith, Nicholas, D.,, US
Bonnefous, Celine,, US
Julien, Jackaline, D.,, US
|
| (73) |
Aragon Pharmaceuticals, Inc.,
12780 El Camino Real, Suite 301, San Diego, CA 92130,
US
|
| (54) | Androgen receptor modulators and uses thereof |
| Androgen receptor modulators and uses thereof |